Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

AGA causes permanent hair loss; women use 2% minoxidil, men use 1 mg finasteride daily.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

New treatments for male hair loss are being explored to improve effectiveness and reduce side effects.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

Patients with mood disorders using 5α-reductase inhibitors may have a higher risk of suicidal thoughts.

5-α-reductase inhibitors don't prevent prostate cancer but may reduce unnecessary biopsies.

Higher doses of 5α-reductase inhibitors may lower mortality risk, but low doses increase it.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

5α-reductase inhibitors help manage symptoms of benign prostatic hyperplasia and may also prevent prostate cancer and treat hair loss.

Testosterone needs to be converted to DHT to reduce stress response in male rats.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

Lack of 5α-Reductase type 1 can lead to insulin resistance and liver problems.

5-Alpha-Reductase inhibitors might help slow down hair loss in Frontal Fibrosing Alopecia but are not a primary treatment and need more research.

A new compound effectively inhibits human 5α-reductase 1.

Oral finasteride and dutasteride may negatively affect erectile function in rats.

Urtica laetevirens extract significantly reduces 5α-reductase activity.

Finasteride effectively lowers specific hormone levels, helping monitor treatment progress.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Key enzymes control androgen levels, affecting hormone activity and potential treatments.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Finasteride may be linked to more psychiatric issues than dutasteride, but a definite cause isn't proven.

The new compound may be a safer alternative to finasteride for prostate protection.